Takeda, CCFA launch IBD awareness initiative, Antibe Therapeutics names Yung Wu to board & more — 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Takeda Pharmaceutical, in partnership with the Crohn's & Colitis Foundation of America, launched IBD Unmasked, a global awareness initiative.

Antibe Therapeutics named Yung Wu to its board of directors and completed enrollment for its phase 2 clinical trial.

SpectraScience signed a distribution agreement with Advanced Medical German in Kuwait.

JP Morgan initiated coverage on EndoChoice's stock.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast